TLDR The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.
This document serves as a resource for paediatricians and primary care providers (PCPs) to adopt an affirming approach when providing routine health care to transgender and gender-diverse (TGD) youth. It offers guidance on counselling TGD youth and their families about medical transition options and making referrals to specialized services. The statement also addresses the growing demand for gender-affirming care, including the initiation of hormone-blocking agents and gender-affirming hormones for adolescents. While not a clinical practice guideline, the document provides foundational information for health care providers (HCPs) interested in developing the necessary skills for such interventions and points to additional resources for acquiring expertise in gender-affirming care.
116 citations,
December 2013 in “The Journal of Pediatrics” Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.
50 citations,
May 2020 in “Journal of Clinical Medicine” Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.
2295 citations,
August 2012 in “The international journal of transgenderism/International journal of transgenderism” The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.
17 citations,
February 2020 in “Journal of Pediatric and Adolescent Gynecology” Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.
8 citations,
December 2022 in “Nature Reviews Endocrinology” Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.
39 citations,
October 2015 in “Case Reports” Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.
